We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
+$2.34B
Cap. Flow
+$2.62B
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
8,008
New
182
Increased
3,096
Reduced
3,760
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 6.16%
2 Financials 5.29%
3 Healthcare 5.26%
4 Consumer Discretionary 4.52%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAAP icon
7276
Corporacion America
CAAP
$4.28B
$3K ﹤0.01%
589
CBAN icon
7277
Colony Bankcorp
CBAN
$460M
$3K ﹤0.01%
186
-1,711
-90% -$27.6K
CGEN icon
7278
Compugen
CGEN
$225M
$3K ﹤0.01%
700
CIX icon
7279
Comp X International
CIX
$342M
$3K ﹤0.01%
227
-193
-46% -$2.93K
CKPT
7280
DELISTED
Checkpoint Therapeutics
CKPT
$3K ﹤0.01%
121
-525
-81% -$14.4K
COGT icon
7281
Cogent Biosciences
COGT
$6.91B
$3K ﹤0.01%
537
CSTL icon
7282
Castle Biosciences
CSTL
$741M
$3K ﹤0.01%
+163
New +$3.61K
DBB icon
7283
Invesco DB Base Metals Fund
DBB
$308M
$3K ﹤0.01%
202
DHY
7284
Credit Suisse High Yield Credit Fund
DHY
$242M
$3K ﹤0.01%
1,121
+25
+2% +$63
ECOR icon
7285
electroCore
ECOR
$50.2M
$3K ﹤0.01%
77
-156
-67% -$4.93K
FOCL
7286
PUT
EDAP TMS S.A.
FOCL
$231M
$3K ﹤0.01%
700
+500
+250% +$1.67K
EEMA icon
7287
iShares MSCI Emerging Markets Asia ETF
EEMA
$830M
$3K ﹤0.01%
54
FNDF icon
7288
Schwab Fundamental International Large Company Index ETF
FNDF
$24.5B
$3K ﹤0.01%
113
FTF
7289
Franklin Limited Duration Income Trust
FTF
$233M
$3K ﹤0.01%
376
+10
+3% +$95
GSIT icon
7290
GSI Technology
GSIT
$222M
$3K ﹤0.01%
398
-3,505
-90% -$29.5K
HSDT icon
7291
Solana Company
HSDT
$98.1M
0
HWBK icon
7292
Hawthorn Bancshares
HWBK
$265M
$3K ﹤0.01%
166
-1,523
-90% -$31.2K
HZO icon
7293
PUT
MarineMax
HZO
$799M
$3K ﹤0.01%
200
INO icon
7294
CALL
Inovio Pharmaceuticals
INO
$79.4M
$3K ﹤0.01%
108
-267
-71% -$8.12K
INSE icon
7295
Inspired Entertainment
INSE
$189M
$3K ﹤0.01%
417
-2,039
-83% -$15.5K
TBHC
7296
DELISTED
The Brand House Collective
TBHC
$3K ﹤0.01%
1,748
-5,106
-74% -$7.93K
KRUS icon
7297
Kura Sushi USA
KRUS
$570M
$3K ﹤0.01%
+129
New +$2.84K
KZR
7298
DELISTED
Kezar Life Sciences
KZR
$3K ﹤0.01%
97
-305
-76% -$14.7K
LEE icon
7299
Lee Enterprises
LEE
$173M
$3K ﹤0.01%
134
-1,233
-90% -$25.1K
LEGH icon
7300
Legacy Housing
LEGH
$628M
$3K ﹤0.01%
192
-1,037
-84% -$14.2K

Similar funds

Citigroup's Q3 2019 Portfolio in Review

As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
  • Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
  • Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
  • Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
  • Citigroup opened 182 new positions and closed 268 in Q3 2019.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.